Continuous Lidocaine Infusion Via Closed Chest Drainage Tube for Pain Control After Thoracoscopic Partial Lung Resection
Lidocaine, Analgesia, Pain, Postoperative

About this trial
This is an interventional treatment trial for Lidocaine
Eligibility Criteria
Inclusion Criteria: participants ages 18-70 years. participants undergoing thoracoscopic partial lung resection with an indwelling drainage tube after surgery. American Society of Anesthesiologists classification (ASA)I-III. Exclusion Criteria: severe heart failure, cardiac arrhythmias,the New York Heart Association(NYHA) classification≥III. hypersensitivity to lidocaine,History of local anesthetic poisoning. severe renal or hepatic dysfunction. body mass index (BMI)>35 kg m-2. severe pleural adhesions.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
lidocaine
normal saline
Patients in this group will receive continuous lidocaine infusion via closed chest drainage tube. The pulse infusion speed is 1ml / 30min, and the continuous infusion speed was 2ml / h.
Patients in this group will receive continuous normal saline infusion via closed chest drainage tube. The pulse infusion speed is same as the lidocaine group.